Acquisition Announced
Eli Lilly acquisition of Engage Bio
US$202m consideration
Announced 20 May 2026
Advisers
Engage Bio
Target
- Legal adviser
- Cooley
Team: Charity Williams, Lindsey O'Crump, Mika Mayer, Lauren Creel, Nitasha Bennett, Alessandra Murata, Josh Himmelstern, Allie Pilmer, Camille Awono, Emily Ianarelli, Ross Eberly, Jonathan Rivinus, Freddy Yip, Stacey Bradford, Megan Browdie, Paula Fleckenstein, Tony Guan, Andrew Epstein, Morgan Perna, Karen Tsai
Eli Lilly
Acquirer
Not disclosed
- Target
- Engage Bio
- Acquirer
- Eli Lilly
- Target based in
- United States (unverified)
- Buyer based in
- United States
- Sector
- Biotech
- Tags
- Biotech, Drug Development
In the league tables
Similar deals
- BioMarin Pharmaceutical acquisition of Alesta Therapeutics Aug 2026 · US$275m · Biotech
- Bayer acquisition of Perfuse Therapeutics May 2026 · US$300m · Biotech
- Gyre Therapeutics acquisition of Cullgen Mar 2026 · US$300m · Biotech
- Dimerix acquisition of MTX652 Jul 2026 · US$292m · Biotech
- Eli Lilly and Company acquisition of CrossBridge Bio Apr 2026 · US$300m · Biotech
Sources
- 20 May 2026 Engage Bio Acquired by Eli Lilly for up to $202 Million cooley.com